← Evidence map

TrialCPT: pharmacometrics & systems pharmacology2025

Population Pharmacokinetics Modeling of Selpercatinib to Support Posology in Pediatric Patients With RET-Altered Metastatic Thyroid Cancer or Solid Tumors.

Dan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 40358020